Nanobiotix (NBTX) Current Leases (2021 - 2023)
Nanobiotix's (NBTX) quarterly Current Leases came in at $1.2 million in Q2 2023, up 3.86% year-on-year from $1.2 million in Q2 2022, and up 3.86% quarter-over-quarter from $1.2 million in Q2 2022.
Nanobiotix (NBTX) Current Leases (2021 - 2023) Analysis & Trends
Nanobiotix's Current Leases history runs 3 years deep, the most recent figure standing at $1.2 million for Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 45.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.25 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Jun 30, 2021 | 1.44 Mn |